In the BioMEMS technology and market report from Yole Développement, the market research and analysis company reports that the BioMEMS market will almost triple in size over the next five years, with mobile care applications contributing significantly to this growth. “The BioMEMS market is expected to grow rapidly, from $1.9B in 2012 to $6.6B in 2018,” says Benjamin Roussel, Technology & Market Analyst, Microfluidics & Medical Technologies at Yole Développement. According to Roussel, microsystems integration is fast becoming a key added-value for system manufacturers.
Microsystem devices have become increasingly visible in the healthcare market by serving as solutions adapted to the requirements of various applications. The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. For example, the introduction of accelerometers in pacemakers has revolutionised the treatment of cardiac diseases. Yole Développement has followed this market’s innovations and key players for several years, and based on an accurate analysis of the market’s last three years, this new report consolidates market data for 2010-2012 and provides forecasts for 2012-2018.
The devices considered in the BioMEMS 2013 report are pressure sensors, silicon microphones, accelerometers, gyroscopes, optical MEMS and image sensors, microfluidic chips, microdispensers for drug delivery, flow meters, infrared temperature sensors, emerging MEMS (RFID, strain sensors,
energy harvesting). For each of the above, Yole Développement’s report provides a market description, the main device and system manufacturers, current market data and forecasts.
The regulation for medical device development, including organisms and process overview, are described for five different regions: Europe, North America, Japan, China and India. This section is particularly important for microsystem device and systems manufacturers.
Microsystem devices have applications in four key healthcare markets: pharmaceutical, in-vitro diagnostics, medical devices and medical homecare. Each of these markets has its own unique dynamics, players and global drivers. Motivation for the acceptance of BioMEMS technologies is highly dependent on each individual market. Whereas the acceptance of microsystems is linked to sensibility and automation constraints in the pharmaceutical market, in the in-vitro diagnostic market it’s all about portability and cost reduction; while the medical device market is focused on addition of functionalities. Concerning the homecare market, the motivations are to increase system safety and connectivity.
Yole Développement’s experts have identified a number of applications for each device type. These
applications can be placed into five groups: patient monitoring, patient care, medical imaging, in-
vitro diagnostic testing and drug delivery. For each of these groups, the report provides an overview
of devices and key market drivers, along with market data. The BioMEMS 2013 report also pays particular attention to Chinese microsystems players, as a number of new players have recently entered the market.
The author of this report is Benjamin Roussel, Market Analyst in microfluidic and medical technologies fields. He holds a State qualification as a Doctor of Pharmacy from the University Claude Bernard Lyon, complemented by a master degree in Technology and Innovation Management from EMLyon Business School.Yvonne Klöpping